Literature DB >> 27448212

Structure and function of the non-classical major histocompatibility complex molecule MR1.

S Harsha Krovi1, Laurent Gapin2.   

Abstract

Polymorphic major histocompatibility complex (MHC) molecules play a central role in the vertebrate adaptive immune system. By presenting short peptides derived from pathogen-derived proteins, these "classical" MHC molecules can alert the T cell branch of the immune system of infected cells and clear the pathogen. There exist other "non-classical" MHC molecules, which while similar in structure to classical MHC proteins, are contrasted by their limited polymorphism. While the functions of many class Ib MHC molecules have still to be elucidated, the nature and diversity of antigens (if any) that some of them might present to the immune system is expected to be more restricted and might function as another approach to distinguish self from non-self. The MHC-related 1 (MR1) molecule is a member of this family of non-classical MHC proteins. It was recently shown to present unique antigens in the form of vitamin metabolites found in certain microbes. MR1 is strongly conserved genetically, structurally, and functionally through mammalian evolution, indicating its necessity in ensuring an effective immune system for members of this class. Although MR1 will be celebrating 21 years this year since its discovery, most of our understanding of how this molecule functions has only been uncovered in the past decade. Herein, we discuss where MR1 is expressed, how it selectively is able to bind to its appropriate antigens and how it, then, is able to specifically activate a distinct population of T cells.

Entities:  

Keywords:  MAIT; MHC-Ib; MR1; TCR; Vitamin metabolites

Mesh:

Substances:

Year:  2016        PMID: 27448212      PMCID: PMC5091073          DOI: 10.1007/s00251-016-0939-5

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  80 in total

Review 1.  Molecular coordination of alphabeta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands.

Authors:  George F Gao; Zihe Rao; John I Bell
Journal:  Trends Immunol       Date:  2002-08       Impact factor: 16.687

Review 2.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

3.  Exceptionally high conservation of the MHC class I-related gene, MR1, among mammals.

Authors:  Kentaro Tsukamoto; Janine E Deakin; Jennifer A Marshall Graves; Keiichiro Hashimoto
Journal:  Immunogenetics       Date:  2012-11-16       Impact factor: 2.846

Review 4.  Recombination centres and the orchestration of V(D)J recombination.

Authors:  David G Schatz; Yanhong Ji
Journal:  Nat Rev Immunol       Date:  2011-03-11       Impact factor: 53.106

Review 5.  Development of invariant natural killer T cells.

Authors:  Laurent Gapin
Journal:  Curr Opin Immunol       Date:  2016-01-21       Impact factor: 7.486

Review 6.  Unconventional recognition of peptides by T cells and the implications for autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Nat Rev Immunol       Date:  2012-09-07       Impact factor: 53.106

7.  Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire.

Authors:  Marco Lepore; Artem Kalinichenko; Artem Kalinicenko; Alessia Colone; Bhairav Paleja; Amit Singhal; Andreas Tschumi; Bernett Lee; Michael Poidinger; Francesca Zolezzi; Luca Quagliata; Peter Sander; Evan Newell; Antonio Bertoletti; Luigi Terracciano; Gennaro De Libero; Lucia Mori
Journal:  Nat Commun       Date:  2014-05-15       Impact factor: 14.919

8.  MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage.

Authors:  Marielle C Gold; James E McLaren; Joseph A Reistetter; Sue Smyk-Pearson; Kristin Ladell; Gwendolyn M Swarbrick; Yik Y L Yu; Ted H Hansen; Ole Lund; Morten Nielsen; Bram Gerritsen; Can Kesmir; John J Miles; Deborah A Lewinsohn; David A Price; David M Lewinsohn
Journal:  J Exp Med       Date:  2014-07-21       Impact factor: 14.307

9.  A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.

Authors:  Sidonia B G Eckle; Richard W Birkinshaw; Lyudmila Kostenko; Alexandra J Corbett; Hamish E G McWilliam; Rangsima Reantragoon; Zhenjun Chen; Nicholas A Gherardin; Travis Beddoe; Ligong Liu; Onisha Patel; Bronwyn Meehan; David P Fairlie; Jose A Villadangos; Dale I Godfrey; Lars Kjer-Nielsen; James McCluskey; Jamie Rossjohn
Journal:  J Exp Med       Date:  2014-07-21       Impact factor: 14.307

10.  Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.

Authors:  Rangsima Reantragoon; Alexandra J Corbett; Isaac G Sakala; Nicholas A Gherardin; John B Furness; Zhenjun Chen; Sidonia B G Eckle; Adam P Uldrich; Richard W Birkinshaw; Onisha Patel; Lyudmila Kostenko; Bronwyn Meehan; Katherine Kedzierska; Ligong Liu; David P Fairlie; Ted H Hansen; Dale I Godfrey; Jamie Rossjohn; James McCluskey; Lars Kjer-Nielsen
Journal:  J Exp Med       Date:  2013-10-07       Impact factor: 14.307

View more
  1 in total

1.  Circulating CD8+ mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients.

Authors:  Victoria M Vorwald; Dana M Davis; Robert J Van Gulick; Robert J Torphy; Jessica Sw Borgers; Jared Klarquist; Kasey L Couts; Carol M Amato; Dasha T Cogswell; Mayumi Fujita; Moriah J Castleman; Timothy Davis; Catherine Lozupone; Theresa M Medina; William A Robinson; Laurent Gapin; Martin D McCarter; Richard P Tobin
Journal:  Clin Transl Immunology       Date:  2022-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.